LLYvsMETA
Eli Lilly and Co vs Meta Platforms Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Eli Lilly and Co
$927.03
-6.70%
Meta Platforms Inc
$688.55
+3.81%
60-day price, rebased to 100
Round-by-round
Valuation upside
-92.70% vs -57.70% to DCF fair value
Balance-sheet strength
Altman Z 15.74 vs 25.49
Fundamental quality
Piotroski 6.00 vs 4.00 (of 9)
Growth + margins
Rule-of-40 -9.10 vs 56.60
60-day momentum
-12.77% vs -3.90% price return
Market-cap liquidity
$884.0B vs $1.26T
Verdict
Across 6 categories, META takes the edge with 5 wins to 1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy on LLY or META
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.